New U.S. Patent Allowance Granted to Mastix LLC for a New Chewing Gum Manufacturing Method Incorporating Cannabinoids
Allows Unique Manufacturing Process for Chewing Gum Products Used to Deliver Active Ingredients Including CBD and THC
Hunt Valley, MD: Mastix LLC, a leading developer and manufacturer of innovative functional food and dietary supplement products, today announces that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application 14/732,072, a utility patent that claims a new manufacturing method for functional chewing gum that covers all forms of powder and oil-based active ingredients, including cannabidiol (CBD) and tetrahydrocannabinol (THC). A Notice of Allowance is issued after the USPTO has determined that a patent will be granted from an application. This platform patent technology covers the inclusion of a wide range of food and supplement active ingredients, including cannabinoids (both naturally extracted and synthetically derived), which is a market currently experiencing explosive growth.
This is the first patent granted to Mastix LLC for its unique chewing gum manufacturing method. Mastix has filed several additional patent applications with the USPTO in this platform technology for the inclusion of cannabinoids into its gum delivery system.
The granting of this notice of allowance for our novel chewing gum dosage form validates the innovative nature of our platform technology and positions us well to offer our customers and consumers an alternative delivery system to pills, capsules and beverages that is widely acceptable and very familiar.
Bob Estey, CEO of Mastix
We have the unique ability to incorporate either a single active ingredient, or multiple active ingredients, into the gum tablets we make to provide our customers with truly custom chewing gum products that will now be patent protected.
“Consumers are actively seeking alternative delivery vehicles for the many pharmaceutical and supplement products they currently take as pills or capsules. Chewing gum is a convenient and discrete way for consumers to quickly and efficiently deliver the benefits they expect from the products they use to improve their health and wellness. The extensive clinical studies the US Military performed on our caffeine gum proved that gum delivered through the oral mucosa is up to five times faster than swallowing pills or capsules while also maintaining high bioavailability of the active.”
In addition to its proprietary MedCBDX gum (www.medcbdx.com), Mastix offers custom product development, contract manufacturing and private label services for its chewing gum, lozenge and chewable tablet product formats. Mastix has developed many tableted products in a wide range of active ingredients including dietary supplements, herbal extracts, probiotics and cannabinoids, and is best known as the supplier of caffeine chewing gum that the US Military packed into its ration kits. Mastix has recently developed several One-of-a-Kind chewing gum products that its contract customers will be introducing to their respective markets very soon.
About Mastix LLC
Mastix LLC develops, manufactures and markets niche functional food and dietary supplement products in chewing gum, chewable tablet and lozenge dosage formats. Mastix manufactures its products in full compliance with FDA GMP (good manufacturing practice) regulations.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
The statements presented in this press release have not been evaluated by the FDA and are not intended to diagnose, treat, cure or prevent any disease.
LEGAL DISCLOSURE
Mastix LLC does not develop, manufacture, sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA).
CONTACT:
Robert Estey
Chief Executive Officer
Mastix LLC
P. 410-316-1080 x100
restey@mastixllc.com
www.mastixmedica.com
Source: Company
